Actively Recruiting
Exercise to Slow Cardiovascular Ageing Progression
Led by National Heart Centre Singapore · Updated on 2025-06-05
450
Participants Needed
1
Research Sites
1443 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In ageing, deleterious alterations in cardiovascular (CV) structure and function increase risks of ageing-related cardiovascular disease (CVD). Investigators found that these CV alterations were associated with circulating serum metabolites, suggesting a metabolic basis to CV ageing. Investigators hypothesize that modification of these metabolites by intervention, such as exercise, may retard CV alterations and reduce CVD in ageing.
CONDITIONS
Official Title
Exercise to Slow Cardiovascular Ageing Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age >=21 years old
- Able to walk outdoors
You will not qualify if you...
- Wheelchair or bed-bound
- Dementia
- Living in sheltered or nursing home
- Cancer
- Participation in ongoing clinical trials involving drugs or devices
- Aneurysms
- Acute infections in the last six months
- Uncontrolled thyrotoxicosis
- Neuromuscular, musculoskeletal, or rheumatoid disorders worsened by exercise
- Uncontrolled asthma or chronic lung disease
- Restrictive lung disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Heart Centre Singapore
Singapore, Singapore, Singapore, 169609
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here